Growth Metrics

Nektar Therapeutics (NKTR) Total Debt: 2011-2020

Historic Total Debt for Nektar Therapeutics (NKTR) over the last 8 years, with Mar 2020 value amounting to $508.9 million.

  • Nektar Therapeutics' Total Debt rose 105.73% to $508.9 million in Q1 2020 from the same period last year, while for Mar 2020 it was $508.9 million, marking a year-over-year increase of 105.73%. This contributed to the annual value of $502.9 million for FY2019, which is 103.64% up from last year.
  • Per Nektar Therapeutics' latest filing, its Total Debt stood at $508.9 million for Q1 2020, which was up 1.20% from $502.9 million recorded in Q4 2019.
  • In the past 5 years, Nektar Therapeutics' Total Debt registered a high of $508.9 million during Q1 2020, and its lowest value of $242.1 million during Q1 2016.
  • Over the past 3 years, Nektar Therapeutics' median Total Debt value was $247.4 million (recorded in 2019), while the average stood at $304.5 million.
  • Data for Nektar Therapeutics' Total Debt shows a peak YoY soared of 105.73% (in 2020) over the last 5 years.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Total Debt stood at $243.5 million in 2016, then grew by 0.72% to $245.2 million in 2017, then rose by 0.71% to $246.9 million in 2018, then soared by 103.64% to $502.9 million in 2019, then spiked by 105.73% to $508.9 million in 2020.
  • Its Total Debt was $508.9 million in Q1 2020, compared to $502.9 million in Q4 2019 and $248.3 million in Q3 2019.